The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors,alleviate the damage of the inflammatory response to the body,and has important value for the treatment of severe COVID-19. Led by academician Li Lanjuan,based on the experience of treating patients across the country,integrating the opinions of experts from all over the country,the center summarized and formulated the consensus including the basic principles,treatment indications,relative contraindications,mode selection,monitoring indicators,and efficacy evaluation of artificial liver,which provides reference for treatment of severe COVID-19 patients.
[1] MUNSTER VJ,KOOPMANS M,van DOREMALEN N,et al. A novel coronavirus emerging in China-key questions for impact assessment[J]. N Engl J Med,2020,382(8):692-694.
|
[2] WONG CK,LAM CW,WU AK,et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome[J]. Clin Exp Immunol,2004,136(1):95-103.
|
[3] HUI DSC,ZUMLA A. Severe acute respiratory syndrome:Historical,epidemiologic,and clinical features[J]. Infect Dis Clin North Am,2019,33(4):869-889.
|
[4] MAHALLAWI WH,KHABOUR OF,ZHANG Q,et al. MERS-Co V infection in humans is associated with a pro-inflammatory Th1and Th17 cytokine profile[J]. Cytokine,2018,104:8-13.
|
[5] de JONG MD,SIMMONS CP,THANH TT,et al. Fatal outcome of human influenza A(H5N1)is associated with high viral load and hypercytokinemia[J]. Nat Med,2006,12(10):1203-1207.
|
[6] GUO J,HUANG F,LIU J,et al. The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes[J]. Sci Rep,2015,5:10942.
|
[7] SADEGHI M,DANIEL V,WANG H,et al. Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients[J]. Transplantation,2013,95(8):1021-1029.
|
[8] LIU X,ZHANG Y,XU X,et al. Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A(H7N9):A cohort study[J]. Ther Apher Dial,2015,19(2):178-184.
|
[9] GAO HN,LU HZ,CAO B,et al. Clinical findings in 111 cases of influenza A(H7N9)virus infection[J]. N Engl J Med,2013,368(24):2277-2285.
|
[10] LI LJ. Artificial liver[M]. Hangzhou:Zhejiang University Press,2012.(in Chinese)李兰娟.人工肝脏[M].杭州:浙江大学出版社,2012.
|
[11] XU KJ,CAI HL,SHEN YH,et al. Management of corona virus disease-19(COVID-19):The Zhejiang experience[J]. J Zhejiang Univ(Med Sci),2020,49(2):147-157.(in Chinese)徐凯进,蔡洪流,沈毅弘,等.2019冠状病毒病(COVID-19)诊疗浙江经验[J].浙江大学学报(医学版),2020,49(2):147-157.
|